Lifecore Biomedical Profit Margin

Lifecore Biomedical (LFCR) currently reports a profit margin of -21.76% as of December 2026. That compares with -24.01% in the prior-year period — up 9.4% year over year. That is below the Materials sector average of 9.56%. Use the charts on this page to explore Lifecore Biomedical's profit margin history and peer comparisons.

Lifecore Biomedical's profit margin increased from -24.01% to -21.76% — a 9.4% year-over-year increase (period ending December 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lifecore Biomedical's profit margin of -21.76% is lower than the Materials sector average of 9.56%. That is roughly 327.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Lifecore Biomedical's current -21.76% should be judged against Materials norms (sector average: 9.56%) and against LFCR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -21.76%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 9.56%. From there, open related valuation or income-statement pages for Lifecore Biomedical, and consider following LFCR for alerts when major investors trade the stock.